News | June 27, 2021
Lupin Launches Emtricitabine and Tenofovir Disoproxil Fumarate Tablets in the US
It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.
It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
Industry members have until 15 July 2026 to submit feedback on proposals seeking additions, deletions and modifications to the Global Tender Enquiry
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,
The backing comes as influenza remains a persistent public health burden
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
